Clinical Trial Update: Evaluation of Oral Care to Prevent Oral Mucositis in ER Positive MBC Patients Treated With Everolimus: Phase 3 RCT [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating whether oral care can prevent oral mucositis in ER-positive metastatic breast cancer patients treated with everolimus; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Everolimus (everolimus)

Snippet

Sponsor: Comprehensive Support Project for Oncology Research | Conditions: Breast Cancer | Phase 3 | Status: COMPLETED